PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
3.620
+0.040 (1.12%)
At close: May 9, 2025, 4:00 PM
3.600
-0.020 (-0.55%)
After-hours: May 9, 2025, 7:06 PM EDT
PetMed Express Market Cap
PetMed Express has a market cap or net worth of $74.67 million as of May 9, 2025. Its market cap has decreased by -14.95% in one year.
Market Cap
74.67M
Enterprise Value
25.67M
1-Year Change
-14.95%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since September 30, 1999, PetMed Express's market cap has increased from $25.50M to $74.67M, an increase of 192.83%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 74.00M | -25.70% |
| Dec 31, 2024 | 99.60M | -37.71% |
| Dec 29, 2023 | 159.90M | -57.13% |
| Dec 30, 2022 | 373.00M | -29.49% |
| Dec 31, 2021 | 529.00M | -18.60% |
| Dec 31, 2020 | 649.90M | 36.97% |
| Dec 31, 2019 | 474.50M | -1.33% |
| Dec 31, 2018 | 480.90M | -48.70% |
| Dec 29, 2017 | 937.50M | 97.99% |
| Dec 30, 2016 | 473.50M | 35.87% |
| Dec 31, 2015 | 348.50M | 19.68% |
| Dec 31, 2014 | 291.20M | -13.28% |
| Dec 31, 2013 | 335.80M | 51.19% |
| Dec 31, 2012 | 222.10M | 5.21% |
| Dec 30, 2011 | 211.10M | -47.98% |
| Dec 31, 2010 | 405.80M | 0.59% |
| Dec 31, 2009 | 403.40M | -2.77% |
| Dec 31, 2008 | 414.90M | 40.07% |
| Dec 31, 2007 | 296.20M | -8.35% |
| Dec 29, 2006 | 323.20M | -3.84% |
| Dec 30, 2005 | 336.10M | 88.61% |
| Dec 31, 2004 | 178.20M | 26.03% |
| Dec 31, 2003 | 141.40M | 332.42% |
| Dec 31, 2002 | 32.70M | 174.79% |
| Dec 31, 2001 | 11.90M | 750.00% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 350.94B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |